|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
multiple interactions |
ISO |
P2RY6 gene affects the reaction [Uridine Diphosphate promotes the reaction [Lipopolysaccharides results in increased secretion of CXCL2 protein]]; Uridine Diphosphate promotes the reaction [Lipopolysaccharides results in increased secretion of CXCL2 protein] |
CTD |
PMID:18523137 |
|
NCBI chr14:18,731,346...18,733,391
Ensembl chr14:18,731,378...18,733,391
|
|
G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
multiple interactions |
ISO |
[Uridine Diphosphate binds to and results in increased activity of CYSLTR1 protein] which results in increased abundance of Calcium; [Uridine Diphosphate binds to and results in increased activity of CYSLTR1 protein] which results in increased expression of CXCL8 protein; montelukast inhibits the reaction [[Uridine Diphosphate binds to and results in increased activity of CYSLTR1 protein] which results in increased abundance of Calcium]; montelukast inhibits the reaction [[Uridine Diphosphate metabolite results in increased activity of CYSLTR1 protein] which results in increased expression of CXCL8 protein]; Uridine Diphosphate binds to and results in increased activity of CYSLTR1 protein; zafirlukast inhibits the reaction [[Uridine Diphosphate binds to and results in increased activity of CYSLTR1 protein] which results in increased abundance of Calcium]; zafirlukast inhibits the reaction [[Uridine Diphosphate metabolite results in increased activity of CYSLTR1 protein] which results in increased expression of CXCL8 protein] |
CTD |
PMID:20083671 |
|
NCBI chr X:77,671,028...77,700,491
Ensembl chr X:77,674,150...77,700,269
|
|
G |
Gpr17 |
G protein-coupled receptor 17 |
multiple interactions |
ISO |
cangrelor inhibits the reaction [Uridine Diphosphate results in increased activity of GPR17 protein] |
CTD |
PMID:18974869 |
|
NCBI chr18:24,733,306...24,739,194
Ensembl chr18:24,734,330...24,735,349
|
|
G |
Idh2 |
isocitrate dehydrogenase (NADP(+)) 2 |
increases abundance multiple interactions |
ISO |
IDH2 protein mutant form results in increased abundance of Uridine Diphosphate Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Uridine Diphosphate] |
CTD |
PMID:27469509 |
|
NCBI chr 1:141,874,354...141,893,674
Ensembl chr 1:141,866,283...141,893,705
|
|
G |
Il6 |
interleukin 6 |
multiple interactions increases expression |
ISO |
MRS 2211 inhibits the reaction [Uridine Diphosphate results in increased expression of IL6 protein]; P2RY6 gene affects the reaction [Uridine Diphosphate promotes the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]]; Uridine Diphosphate promotes the reaction [Lipopolysaccharides results in increased secretion of IL6 protein] |
CTD |
PMID:18523137 PMID:24849676 |
|
NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
increases phosphorylation multiple interactions |
ISO |
Uridine Diphosphate results in increased phosphorylation of MAPK1 protein P2RY6 gene mutant form inhibits the reaction [Uridine Diphosphate results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:15034929 PMID:18523137 |
|
NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
increases phosphorylation multiple interactions |
ISO |
Uridine Diphosphate results in increased phosphorylation of MAPK3 protein P2RY6 gene mutant form inhibits the reaction [Uridine Diphosphate results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:15034929 PMID:18523137 |
|
NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
|
|
G |
P2ry6 |
pyrimidinergic receptor P2Y6 |
multiple interactions affects response to substance |
ISO |
P2RY6 gene affects the reaction [Uridine Diphosphate promotes the reaction [Lipopolysaccharides results in increased secretion of CXCL2 protein]]; P2RY6 gene affects the reaction [Uridine Diphosphate promotes the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]]; P2RY6 gene mutant form inhibits the reaction [Uridine Diphosphate results in increased phosphorylation of MAPK1 protein]; P2RY6 gene mutant form inhibits the reaction [Uridine Diphosphate results in increased phosphorylation of MAPK3 protein] P2RY6 gene affects the susceptibility to Uridine Diphosphate |
CTD |
PMID:18523137 |
|
NCBI chr 1:165,972,439...166,008,348
Ensembl chr 1:165,972,440...165,997,751
|
|
|
G |
Gale |
UDP-galactose-4-epimerase |
affects binding |
ISO |
Uridine Diphosphate Galactose binds to GALE protein |
CTD |
PMID:25526675 |
|
NCBI chr 5:154,310,453...154,314,959
Ensembl chr 5:154,310,453...154,314,955
|
|
G |
Gpr17 |
G protein-coupled receptor 17 |
increases activity |
ISO |
Uridine Diphosphate Galactose results in increased activity of GPR17 protein |
CTD |
PMID:18974869 |
|
NCBI chr18:24,733,306...24,739,194
Ensembl chr18:24,734,330...24,735,349
|
|
G |
Uxs1 |
UDP-glucuronate decarboxylase 1 |
multiple interactions |
ISO |
[Uridine Diphosphate Galactose co-treated with NAD] binds to UXS1 protein |
CTD |
PMID:25526675 |
|
NCBI chr 9:11,165,006...11,240,329
Ensembl chr 9:11,164,715...11,339,790
|
|
|
G |
Gale |
UDP-galactose-4-epimerase |
affects binding |
ISO |
Uridine Diphosphate Glucose binds to GALE protein |
CTD |
PMID:25526675 |
|
NCBI chr 5:154,310,453...154,314,959
Ensembl chr 5:154,310,453...154,314,955
|
|
G |
Gpr17 |
G protein-coupled receptor 17 |
increases activity |
ISO |
Uridine Diphosphate Glucose results in increased activity of GPR17 protein |
CTD |
PMID:18974869 |
|
NCBI chr18:24,733,306...24,739,194
Ensembl chr18:24,734,330...24,735,349
|
|
G |
Uxs1 |
UDP-glucuronate decarboxylase 1 |
multiple interactions |
ISO |
[Uridine Diphosphate Glucose co-treated with NAD] binds to UXS1 protein |
CTD |
PMID:25526675 |
|
NCBI chr 9:11,165,006...11,240,329
Ensembl chr 9:11,164,715...11,339,790
|
|
|
G |
B3gat3 |
beta-1,3-glucuronyltransferase 3 |
affects binding multiple interactions |
ISO |
B3GAT3 protein binds to Uridine Diphosphate Glucuronic Acid Uridine Diphosphate Glucuronic Acid inhibits the reaction [Diacetyl results in decreased activity of B3GAT3 protein] |
CTD |
PMID:11986319 |
|
NCBI chr 1:225,120,061...225,126,579
Ensembl chr 1:225,120,061...225,126,579
|
|
G |
Gale |
UDP-galactose-4-epimerase |
affects binding |
ISO |
Uridine Diphosphate Glucuronic Acid binds to GALE protein |
CTD |
PMID:25526675 |
|
NCBI chr 5:154,310,453...154,314,959
Ensembl chr 5:154,310,453...154,314,955
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
increases expression |
ISO |
Uridine Diphosphate Glucuronic Acid results in increased expression of PPARGC1A mRNA |
CTD |
PMID:23056435 |
|
NCBI chr14:63,095,291...63,190,688
Ensembl chr14:63,095,720...63,187,009
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase family 1 member A1 |
multiple interactions |
ISO |
[Uridine Diphosphate Glucuronic Acid co-treated with UGT1A1 protein] results in increased glucuronidation of Labetalol |
CTD |
PMID:18098064 |
|
NCBI chr 9:95,295,701...95,302,822
Ensembl chr 9:95,161,157...95,302,822
|
|
G |
Ugt2b7 |
UDP glucuronosyltransferase family 2 member B7 |
multiple interactions |
ISO |
[Uridine Diphosphate Glucuronic Acid co-treated with UGT2B7 protein] results in increased glucuronidation of Labetalol; Fluconazole inhibits the reaction [[Uridine Diphosphate Glucuronic Acid co-treated with UGT2B7 protein] results in increased glucuronidation of Labetalol] |
CTD |
PMID:18098064 |
|
NCBI chr14:22,597,103...22,619,968
|
|
G |
Uxs1 |
UDP-glucuronate decarboxylase 1 |
multiple interactions |
ISO |
[Uridine Diphosphate Glucuronic Acid co-treated with NAD] binds to UXS1 protein |
CTD |
PMID:25526675 |
|
NCBI chr 9:11,165,006...11,240,329
Ensembl chr 9:11,164,715...11,339,790
|
|
|
G |
Gale |
UDP-galactose-4-epimerase |
affects binding |
ISO |
Uridine Diphosphate Galactose binds to GALE protein |
CTD |
PMID:25526675 |
|
NCBI chr 5:154,310,453...154,314,959
Ensembl chr 5:154,310,453...154,314,955
|
|
G |
Gpr17 |
G protein-coupled receptor 17 |
increases activity |
ISO |
Uridine Diphosphate Galactose results in increased activity of GPR17 protein |
CTD |
PMID:18974869 |
|
NCBI chr18:24,733,306...24,739,194
Ensembl chr18:24,734,330...24,735,349
|
|
G |
Uxs1 |
UDP-glucuronate decarboxylase 1 |
multiple interactions |
ISO |
[Uridine Diphosphate Galactose co-treated with NAD] binds to UXS1 protein |
CTD |
PMID:25526675 |
|
NCBI chr 9:11,165,006...11,240,329
Ensembl chr 9:11,164,715...11,339,790
|
|
|
G |
Gale |
UDP-galactose-4-epimerase |
affects binding |
ISO |
Uridine Diphosphate Glucose binds to GALE protein |
CTD |
PMID:25526675 |
|
NCBI chr 5:154,310,453...154,314,959
Ensembl chr 5:154,310,453...154,314,955
|
|
G |
Gpr17 |
G protein-coupled receptor 17 |
increases activity |
ISO |
Uridine Diphosphate Glucose results in increased activity of GPR17 protein |
CTD |
PMID:18974869 |
|
NCBI chr18:24,733,306...24,739,194
Ensembl chr18:24,734,330...24,735,349
|
|
G |
Uxs1 |
UDP-glucuronate decarboxylase 1 |
multiple interactions |
ISO |
[Uridine Diphosphate Glucose co-treated with NAD] binds to UXS1 protein |
CTD |
PMID:25526675 |
|
NCBI chr 9:11,165,006...11,240,329
Ensembl chr 9:11,164,715...11,339,790
|
|
|
G |
Gale |
UDP-galactose-4-epimerase |
affects binding |
ISO |
Uridine Diphosphate N-Acetylgalactosamine binds to GALE protein |
CTD |
PMID:25526675 |
|
NCBI chr 5:154,310,453...154,314,959
Ensembl chr 5:154,310,453...154,314,955
|
|
|
G |
Idh2 |
isocitrate dehydrogenase (NADP(+)) 2 |
multiple interactions increases abundance |
ISO |
Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Uridine Diphosphate N-Acetylglucosamine] |
CTD |
PMID:27469509 |
|
NCBI chr 1:141,874,354...141,893,674
Ensembl chr 1:141,866,283...141,893,705
|
|